Larvol Delta - HeberNasvac-a-Therapeutic-Vaccine-for-Chronic-Hepatitis-B-Stimulates-Local-and-Systemic-Markers-of-Innate-Immunity-Potential-Use-in-SARSCoV2-Postexposure-Prophylaxis

HeberNasvac (ABX203) - Center for Genetic Engineering and Biotechnology, Abivax

http://www.ncbi.nlm.nih.gov/pubmed/34786358

Nov 22, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next